Education
About Us
Working with TipRanks
Follow Us
Teva Pharmaceutical Industries Limited (IL:TEVA)
:TEVA
Total Valuation
Teva has a market cap or net worth of 68.23B. The enterprise value is ―.
Market Cap68.23B
Enterprise Value―
Share Statistics
Teva has 1,146,838,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,146,838,700
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Teva’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee467.54K
Profits Per Employee-16.49K
Employee Count33,892
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Teva is ―. Teva’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Teva had revenue of 15.85B and earned -559.00M in profits. Earnings per share was -0.50.
Revenue15.85B
Gross Profit7.65B
Operating Income433.00M
Pretax Income-622.00M
Net Income-559.00M
EBITDA1.56B
Earnings Per Share (EPS)-0.50
Cash Flow
In the last 12 months, operating cash flow was 1.86B and capital expenditures -488.00M, giving a free cash flow of 1.37B billion.
Operating Cash Flow1.86B
Free Cash Flow1.37B
Free Cash Flow per Share1.19
Dividends & Yields
Teva pays an annual dividend of 29.7, resulting in a dividend yield of ―
Dividend Per Share29.7
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.71
52-Week Price Change3.79%
50-Day Moving Average5.70K
200-Day Moving Average6.46K
Relative Strength Index (RSI)61.50
Average Volume (3m)2.54M
Important Dates
Teva upcoming earnings date is Aug 6, 2025, TBA Not Confirmed.
Last Earnings DateMay 7, 2025
Next Earnings DateAug 6, 2025
Ex-Dividend DateNov 28, 2017
Financial Position
Teva as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Teva has paid -7.00M in taxes.
Income Tax-7.00M
Effective Tax Rate―
Enterprise Valuation
Teva EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Teva has 3.32B in cash and marketable securities with $19.27B in debt, giving a net cash position of 15.96B billion.
Cash & Marketable Securities3.32B
Total Debt$19.27B
Net Cash15.96B
Net Cash Per Share13.91
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Teva is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast2.44%
EPS Growth Forecast-197.12%